Topics

Medicrea Reports First Quarter 2019 Sales

19:11 EDT 10 Apr 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
STRONG GROWTH IN UNID® PATIENT-SPECIFIC SURGERIES IN THE USA: +68% WW SALES INCREASED BY 10% IN Q1 (+6% at constant exchange rate) USA SALES INCREASED BY 15% IN Q1 (+8% at constant exchange rate)...

Other Sources for this Article

Medicrea
Denys SOURNAC
Founder, Chairman and CEO
dsournac@medicrea.com

Fabrice KILFIGER
Chief Financial Officer
fkilfiger@medicrea.com
Tel: +33 (0)4 72 01 87 87

NEXT ARTICLE

More From BioPortfolio on "Medicrea Reports First Quarter 2019 Sales"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...